John Delyani

John Delyani serves as Chief Business Officer at Repertoire Immune Medicines. Repertoire Immune Medicines operates in the research sector with approximately 83.0 employees. The company is headquartered in Cambridge, Massachusetts. Repertoire Immune Medicines generates annual revenue of 450000.0. To date, Repertoire Immune Medicines has raised 254000000.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,468 c suite-level executives.

Mimecast Outlook Nginx Mobile Friendly Render

biotechnology research immune medicines t cell receptor autoimmune diseases cancer treatment decode platform tcr bispecifics mrna vaccines therapeutic approaches immune synapse immunogenic epitopes tumor-specific therapies clinical development targeted immune suppression antigen presentation cd8+ t cells immune balance t cell activation biologics adaptive immune system cellular immune responses molecular science disease-relevant epitopes therapeutics pipeline precision medicine personalized therapies immune modulation biotech innovation immune evasion solid tumors hematological cancers regulatory t cells tolerizing vaccines epitope mapping immune homeostasis t cell specificity immune monitoring patient equity drug development cancer vaccines hla diversity immune responses clinical trials pharmaceutical collaboration tumor recognition immune therapy lipid nanoparticle delivery disease remission innovative therapeutics therapy scalability clinical-stage biotechnology immune therapies programmable immune medicines t cell repertoire oncology infectious diseases therapeutic innovation immune system programming patient-centric solutions strategic collaborations bristol myers squibb partnership advanced clinical trials immune synapse insights transformative treatments health conditions immune balance restoration targeted therapies immuno-oncology disease prevention patient populations healthcare institutions research partnerships biopharmaceutical industry health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like John Delyani in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Repertoire Immune Medicines.

John Delyani's Position in the MessageCEO Database

• •John Delyani is 1 of 1 verified executive contact we track at Repertoire Immune Medicines.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •7 verified contacts work at research companies in the 83.0 employee range (same size as Repertoire Immune Medicines).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach John Delyani directly?

John Delyani's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at Repertoire Immune Medicines. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does John Delyani work for?

John Delyani is Chief Business Officer at Repertoire Immune Medicines, a company in the research sector with 83.0 employees. The company is based in Cambridge, Massachusetts.

Can I pitch or sell to John Delyani?

As Chief Business Officer at Repertoire Immune Medicines, John Delyani is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach John Delyani directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is John Delyani in?

John Delyani works in the research industry as Chief Business Officer at Repertoire Immune Medicines. MessageCEO provides verified contact information for executives across all major industries.

Is John Delyani's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. John Delyani's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026